An article from the New England Journal of Medicine presents evidence for the effectiveness of single-dose HPV vaccination in preventing cervical HPV infection. The study shows that a single dose of the vaccine provides significant protection against infection with HPV viruses that are linked to cervical cancer. The results suggest that single-dose vaccination may be as effective as a standard multi-dose regimen. This approach could improve vaccine availability and increase vaccination rates, especially in low-income countries. The study emphasizes that reducing the number of doses does not reduce protection against the most risky types of HPV. These findings support a change in vaccination recommendations and a wider introduction of single-dose vaccination into practice. Overall, the article provides strong evidence for the effective use of single-dose vaccination to reduce the incidence of cervical HPV infection.